1. Academic Validation
  2. Activation of CFTR by UCCF-029 and genistein

Activation of CFTR by UCCF-029 and genistein

  • Bioorg Med Chem Lett. 2008 Jul 15;18(14):3874-7. doi: 10.1016/j.bmcl.2008.06.051.
Layla Al-Nakkash 1 Mark F Springsteel Mark J Kurth Michael H Nantz
Affiliations

Affiliation

  • 1 Department of Physiology, Midwestern University, 19555 N 59th Avenue, Glendale, AZ 85308, USA. [email protected]
Abstract

The mechanism of action of a novel CFTR Activator UC(CF)-029 on NIH3T3 cells stably expressing DeltaF508-CFTR was investigated and its effects compared to those of genistein, a known CFTR Activator. This study shows that UC(CF)-029 and genistein have differing efficacies. The efficacy of UC(CF)-029 in the presence of forskolin (10microM) is approximately 50% that of genistein; however, the EC(50)'s for both drugs are comparable; 3.5microM for UC(CF)-029 and 4.4muM for genistein. Using NIH3T3 cells stably transfected with K1250A-CFTR we find that CFTR channel open time is unaffected by UC(CF)-029 or genistein, supporting the hypothesis that these compounds stabilize the open state by inhibiting ATP hydrolysis at NBD2. Our data suggest that the ability of UC(CF)-029 to augment DeltaF508-CFTR channel activity necessitates further interest.

Figures